Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) insider Geus Aart De sold 25,000 shares of the stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $445.55, for a total value of $11,138,750.00. Following the transaction, the insider directly owned 120,421 shares of the company’s stock, valued at approximately $53,653,576.55. This trade represents a 17.19% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Synopsys Stock Down 0.7%
SNPS opened at $439.59 on Tuesday. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $615.79. The stock has a market capitalization of $84.24 billion, a P/E ratio of 77.67, a P/E/G ratio of 2.42 and a beta of 1.23. The business has a 50 day simple moving average of $416.14 and a 200-day simple moving average of $440.15.
Synopsys (NASDAQ:SNPS – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.Synopsys’s quarterly revenue was up 42.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities analysts anticipate that Synopsys, Inc. will post 11.03 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Analyst Ratings Changes
A number of equities analysts have recently issued reports on the stock. Berenberg Bank set a $633.00 price target on shares of Synopsys in a report on Wednesday, May 27th. Citigroup boosted their price objective on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Stifel Nicolaus upped their target price on shares of Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Bank of America increased their target price on shares of Synopsys from $515.00 to $600.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Finally, Robert W. Baird upgraded shares of Synopsys from a “neutral” rating to an “outperform” rating and lifted their price target for the company from $558.00 to $560.00 in a research report on Thursday. Twelve equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Synopsys presently has an average rating of “Moderate Buy” and an average target price of $561.28.
Get Our Latest Research Report on SNPS
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
